The Usefulness of Preoperative Thyroid-Stimulating Hormone for Predicting Differentiated Thyroid Microcarcinoma

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Otolaryngology Head & Neck Surgery

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0194599815618388PMID 26598500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER.

  2015cited by this paper
• [Relationship between serum thyroxin-stimulating hormone and papillary thyroid micrcarcinoma in nodular thyroid disease].

  2015cited by this paper
• Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.

  2015cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Lack of association between high serum thyroid‐stimulating hormone level and risk of papillary thyroid microcarcinomas

  2014cited by this paper
• BRAF V600E mutation and papillary thyroid cancer.

  2013cited by this paper
• BRAF V600E mutation and papillary thyroid cancer.

  2013cited by this paper
• Controversies in primary treatment of low-risk papillary thyroid cancer.

  2013cited by this paper
• Thyrotropin values in patients with micropapillary thyroid cancer versus benign nodular disease.

  2013cited by this paper
• Incidental thyroid cancer in toxic and nontoxic goiter: Is TSH associated with malignanCy rate? Results of a meta-analysis.

  2013cited by this paper
• Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules.

  2012cited by this paper
• Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule

  2012influential reference
• Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis.

  2012cited by this paper
• Preoperative Thyrotropin Serum Concentrations Gradually Increase from Benign Thyroid Nodules to Papillary Thyroid Microcarcinomas Then to Papillary Thyroid Cancers of Larger Size

  2011cited by this paper
• Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptake.

  2011cited by this paper
• Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice

  2011cited by this paper
• Thyrotropin Serum Concentrations in Patients with Papillary Thyroid Microcancers

  2010cited by this paper
• The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.

  2009cited by this paper
• The BRAF V600E Oncogene Induces Transforming Growth Factor β Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer

  2009cited by this paper
• Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.

  2008cited by this paper
• BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.

  2007cited by this paper
• Thyroid cancer yield in patients with Graves' disease.

  2003cited by this paper
• Growth factors and goitrogenesis.

  1999cited by this paper
• Cancer statistics

  1989cited by this paper

• Role of Thyroid Function Test as a Predictor of Benign or Malignant Nature of Thyroid Swelling

  2025cites this paper
• TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients

  2023cites this paper
• Establishment of a predictive nomogram for differentiated thyroid cancer: an inpatient-based retrospective study.

  2023cites this paper
• Thyroid Cancer Incidence Differences Between Men and Women

  2023cites this paper
• A Review of Evidence for the Involvement of the Circadian Clock Genes into Malignant Transformation of Thyroid Tissue

  2023cites this paper
• Prospects of Testing Diurnal Profiles of Expressions of TSH-R and Circadian Clock Genes in Thyrocytes for Identification of Preoperative Biomarkers for Thyroid Carcinoma

  2022cites this paper
• The associations between thyroid-related hormones and the risk of thyroid cancer: An overall and dose-response meta-analysis

  2022cites this paper
• The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis.

  2022cites this paper
• The Effect of ThyroidߚStimulating Hormone on Stage of Differentiated Thyroid Carcinoma

  2021cites this paper
• Preoperative thyroid-stimulating hormone associated risk of differentiated thyroid cancer in patients with thyroid nodules.

  2021cites this paper
• Predictive Values of Inflammation-Related Markers and Thyroid Function in Pediatric Thyroid Cancer Patients

  2021cites this paper
• Higher TSH is not associated with thyroid cancer risk in the presence of thyroid autoimmunity.

  2020cites this paper
• The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thyroid cancer in patients with thyroid nodules: A systematic review and meta-analysis.

  2020cites this paper
• Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment

  2020cites this paper
• TSH and thyroid cancer (literature analysis and results of own research)

  2019cites this paper
• Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer

  2018cites this paper
• The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma

  2018cites this paper
• Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β

  2017cites this paper
• Highlights from the Current Issue

  2016cites this paper
• Active surveillance as the initial treatment of papillary thyroid microcarcinoma: a 10-years multicentric prospective study

  2016cites this paper
• WOMEN IN CANCER THEMATIC REVIEW: Thyroid-stimulating hormone in thyroid cancer: does it matter?

  2016cites this paper